General measures and basic treatment

Badalian, S. S., Silverman, R. K., Aubry, R. H., et al. (2000) Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med, 45, 149-152.

Barst, R. J. (2000) Role of atrial septostomy in the treatment of pulmonary vascular disease. Thorax, 55, 95-96.

Bärtsch, P. (1997) High altitude pulmonary edema. Respiration, 64, 435-443.

Bärtsch, P., Maggiorini, M., Ritter, M., et al. (1991) Prevention of high altitude pulmonary edema by nifedipine. N Engl J Med, 325, 1284-1289.

Borst, M. M., Leschke, M., Konig, U., et al. (1999) Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: effects on pulmonary hemodynamics, gas exchange, and exercise capacity. Respiration, 66, 225-232.

Brimioulle, S., Vachiery, J. L., Brichant, J. F., et al. (1997) Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res, 34, 384-392.

Brown, S. E., Pakron, F. J., Milne, N., et al. (1984) Effects of digoxin on exercise capacity and right ventricular function during exercise in chronic airflow obstruction. Chest, 85, 187-191.

Cargill, R. I. and Lipworth, B. J. (1996) Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest, 109, 424-429.

Cinar, Y., Demir, G., Pac, M., et al. (1999) Effect of hematocrit on blood pressure via hyperviscosity. Am J Hypertens, 12, 739-743.

Clarke, W. R., Horn, J. R., Kawabori, I., et al. (1993) Potentially serious drug interactions secondary to high-dose diltiazem used in the treatment of pulmonary hypertension. Pharmacotherapy, 13, 402-405.

Cotter, G., Metzkor, E., Kaluski, E., et al. (1998) Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet, 351, 389-393.

Defouilloy, C., Teiger, E., Sediame, S., et al. (1998) Polycythemia impairs vasodilator response to acetylcholine in patients with chronic hypoxemic lung disease. Am J Respir Crit Care Med, 157, 1452-1460.

Delcroix, M., Lejeune, P., Ewalenko, P., et al. (1995) Effects of inotropic agents on right ventriculo-vascular coupling in canine embolism. Eur Respir J, 8, 467S.

Easterling, T. R., Ralph, D. D. and Schmucker, B. C. (1999) Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol, 93, 494-498.

Eddahibi, S., Adnot, S., Frisdal, E., et al. (2001) Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther, 297, 148-154.

Fletcher, E. C., Luckett, R. A., Goodnight-White, S., et al. (1992) A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis, 145, 1070-1076.

Goodwin, T. M., Gherman, R. B., Hameed, A., et al. (1999) Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol, 180, 64-67.

Groves, B. M., Reeves, J. T., Sutton, J. R., et al. (1987) Operation Everest II: elevated high altitude pulmonary resistence unresponsive to oxygen. J. Appl. Physiol., 63, 521-530.

Helmerhorst, F. M., Bloemenkamp, K. W., Rosendaal, F. R., et al. (1997) Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb Haemost, 78, 327-333.

Hultgren, H. N. (1975) Furosemide for high altitude pulmonary edema. JAMA, 234, 589-590.

Julien, M., Hakim, T. S., Vahi, R., et al. (1985) Effect of hematocrit on vascular pressure profile in dog lungs. J Appl Physiol, 58, 743-748.

Kiely, D. G., Cargill, R. I. and Lipworth, B. J. (1995) Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade. Cardiovasc Res, 30, 875-880.

Kiely, D. G., Cargill, R. I., Wheeldon, N. M., et al. (1997) Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res, 33, 201-208.

Kleiger, R. E., Boxer, M., Ingham, R. E., et al. (1976) Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest, 69, 143-147.

Leeman, M., Delcroix, M., Vachiery, J. L., et al. (1992) Blunted hypoxic vasoconstriction in oleic acid lung injury: effect of cyclooxygenase inhibitors. J Appl Physiol, 72, 251-258.

Lewis, M. A. (1998) The epidemiology of oral contraceptive use: a critical review of the studies on oral contraceptives and the health of young women. Am J Obstet Gynecol, 179, 1086-1097.

Maggiorini, M., Mélot, C., Pierre, S., et al. (2001) High altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation, 103, 2078-2083.

Marticorena, E. and Hultgren, H. N. (1979) Evaluation of therapeutic method in high altitude pulmonary edema. Am. J. Cardiol., 43, 307-312.

Mathur, P. N., Powles, P., Pugsley, S. O., et al. (1981) Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial. Ann Intern Med, 95, 283-288.

Muikku, O., Hynynen, M., Salmenpera, M., et al. (1996) Pulmonary vascular effects of nitroglycerin and isosorbide dinitrate in patients with end-stage cardiomyopathies. Acta Anaesthesiol Scand, 40, 909-912.

Murali, S., Uretsky, B. F., Armitage, J. M., et al. (1992) Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant, 11, 716-723.

Naeije, R. (1996) Pulmonary vascular function. In: Pulmonary circulation. A handbook for clinicians.(Ed, Peacock, A. J.) Chapman & Hall Medical, London, pp. 13-27.

Naeije, R., De Backer, D., Vachiery, J. L., et al. (1996) High-altitude pulmonary edema with primary pulmonary hypertension. Chest, 110, 286-289.

Naeije, R., Hallemans, R., Mélot, C., et al. (1987) Ecosanoids and hypoxic pulmonary vasoconstriction in normal man. Bull Eur Physiopathol Respir, 23, 613-618.

Naeije, R., Wauthy, P., Maggiorini, M., et al. (1995) Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. Am J Respir Crit Care Med, 151, 692-697.

Nihill, M. R., McNamara, D. G. and Vick, R. L. (1976) The effects of increased blood viscosity on pulmonary vascular resistance. Am Heart J, 92, 65-72.

Northridge, D. (1996) Frusemide or nitrates for acute heart failure? Lancet, 347, 667-668.

Opravil, M., Pechere, M., Speich, R., et al. (1997) HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med, 155, 990-995.

Packer, M., Halperin, J. L., Brooks, K. M., et al. (1984) Nitroglycerin therapy in the management of pulmonary hypertensive disorders. Am J Med, 76, 67-75.

Pearl, R. G., Rosenthal, M. H., Schroeder, J. S., et al. (1983) Acute hemodynamic effects of nitroglycerin in pulmonary hypertension. Ann Intern Med, 99, 9-13.

Persson, S. U., Gustavsson, C. G., Larsson, H., et al. (1991) Studies on blood rheology in patients with primary pulmonary hypertension. Angiology, 42, 836-842.

Pugliese, A., Isnardi, D., Saini, A., et al. (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect, 40, 282-284.

Rich, S., Seidlitz, M., Dodin, E., et al. (1998) The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest, 114, 787-792.

Richardson, T. G. and Guyton, A. C. (1959) Effects of polycytemia and anemia on cardiac output and other circulatory factors. Am J Physiol, 197, 1167.

Saadjian, A., Philip-Joet, F., Levy, S., et al. (1992) Vascular and cardiac reactivity in pulmonary hypertension due to chronic obstructive lung disease: assessment with various oxygen concentrations. Eur Respir J, 5, 525-530.

Schmid, E. R., Burki, C., Engel, M. H., et al. (1999) Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Anesth Analg, 89, 1108-1115.

Stewart, R., Tuazon, D., Olson, G., et al. (2001) Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy. Chest, 119, 973-975.

Townend, J. N., Roberts, D. H., Jones, E. L., et al. (1992) Fatal pulmonary venoocclusive disease after use of oral contraceptives. Am Heart J, 124, 1643-1644.

Turanlahti, M. I., Laitinen, P. O., Sarna, S. J., et al. (1998) Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension. Heart, 79, 169-174.

Weiss, B. M., Maggiorini, M., Jenni, R., et al. (2000) Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology, 92, 1191-1194.

Weiss, B. M., Zemp, L., Seifert, B., et al. (1998) Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol, 31, 1650-1657.

Weisse, A. B., Moschos, C. B., Frank, M. J., et al. (1975) Hemodynamic effects of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels. Am J Med, 58, 92-98.

Wiedermann, H. P. and Matthay, R. A. (1989) The management of acute and chronic cor pulmonale. In: Heart-lung interactions in health and disease, Vol. 42 (Eds, Scharf, S. M. and Cassidy, S. S.) Marcel Dekker, Inc., New York, Basel, pp. 915-981.

Wisenbaugh, T., Essop, R., Middlemost, S., et al. (1993) Pulmonary hypertension is a contraindication to beta-blockade in patients with severe mitral stenosis. Am Heart J, 125, 786-790.

Yoshida, M., Taguchi, O., Gabazza, E. C., et al. (1997) Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 155, 526-529.

Zielinski, J., Hawrylkiewicz, I., Gorecka, D., et al. (1986) Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. Chest, 90, 562-565.